Abstract
By Michael Victor Caldwell Mr., GCI
GCI Oncology Suite v2.1 integrates 5 validated subsystems for non-invasive solid tumor treatment: #16 Acoustophoresis: 85% EV/microplastic blood prep (+112% delivery) #23 Arachne Fermat spiral: 10% bone loss propagation #24 VPO Drill: 4.7x microbubble clustering (l=1 vortex) #25 BRR + #11 Exhaust: < 400nm protein aggregates (45° VFD) #36 FUS: Pre-focus sequence
Targets 6.2x bio-delivery vs 1.8x AVT std. Safety: PCD/TI< 0.7. BOM $38k; UNR phantom trials Mar 2026. Prior MS: #10651 (#23). Humanitarian: CERN-OHL-P - Build freely for patients.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Caldwell, Michael Victor Mr., "GCI Oncology Suite v2.1: Vortex IFP Bypass + Protein Refold (CERN-OHL-P)", Technical Disclosure Commons, (March 05, 2026)
https://www.tdcommons.org/dpubs_series/9453